CN Patent

CN101584652A — 利培酮缓释凝胶注射剂及其制备方法

Assigned to Shanghai Pharmaceutical Stock Co ltd · Expires 2009-11-25 · 16y expired

What this patent protects

本发明公开了一种利培酮缓释凝胶注射剂及其制备方法。该利培酮缓释凝胶注射剂由利培酮或其类似物、生物可降解聚合物和生物相容性溶剂组成，其中利培酮或其类似物与生物可降解聚合物和生物相容性溶剂之和的质量比为1∶3－67。该注射剂注射到体内适当部位后即能立刻持续、恒速释放利培酮达数周，从而改善精神病患者利培酮类似物治疗的顺应性。

USPTO Abstract

本发明公开了一种利培酮缓释凝胶注射剂及其制备方法。该利培酮缓释凝胶注射剂由利培酮或其类似物、生物可降解聚合物和生物相容性溶剂组成，其中利培酮或其类似物与生物可降解聚合物和生物相容性溶剂之和的质量比为1∶3－67。该注射剂注射到体内适当部位后即能立刻持续、恒速释放利培酮达数周，从而改善精神病患者利培酮类似物治疗的顺应性。

Drugs covered by this patent

Patent Metadata

Patent number
CN101584652A
Jurisdiction
CN
Classification
—
Expires
2009-11-25
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Pharmaceutical Stock Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.